Note: Zepbound (tirzepatide), not Wegovy, received OSA approval
Researchers designing combination protocols can order separate batches with separate batch-specific COAs, which is generally required for research protocol documentation regardless of whether the compounds are used sequentially or in parallel
The rate of weight loss on Wegovy can vary, but many of my patients notice results within the first few weeks
In a phase 1b trial, it demonstrated robust weight loss in people with obesity, exceeding placebo by a meaningful margin
If a settlement isnt reached, your case will be presented in trial
In a 2016 study of G6PD testing prior to the administration of rasburicase in a large healthcare system, only 20.3% of patients identified as high risk for G6PD deficiency were tested